According to a recent report by J.P. Morgan, during a McKesson conference call MCK, CEO, John Hammergren reported the company has no plans to sell or spin their business and further discussed recent trends and management outlook. The conference call lead J.P. Morgan to reiterate a $84.17 price target and Overweight rating.
In the report, J.P. Morgan said, "After a disappointing F4Q11 relative to investor and management expectations within Technology Solutions, management reiterated on our conference call that the weakness was associated with the implementation of the Horizon product within mid- to large-size hospitals."
McKesson closed yesterday at $83.51.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care DistributorsJ.P. MorganMcKesson Corporation
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in